{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=9345&max-ddpModified.=2019-07-02T12%3A15%3A06.860Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=9345&max-ddpModified.=2019-07-02T12%3A15%3A06.860Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=9345&max-ddpModified.=2019-07-02T12%3A15%3A06.860Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=9345&_page=0&max-ddpModified.=2019-07-02T12%3A15%3A06.860Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=9345&max-ddpModified.=2019-07-02T12%3A15%3A06.860Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=9345&max-ddpModified.=2019-07-02T12%3A15%3A06.860Z", "items" : [{"_about" : "http://data.parliament.uk/resources/758626", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/758626/answer", "answerText" : {"_value" : "

The government has committed to invest almost £1.6 billion in City Deals in Scotland and Wales. Of this, £500m will be invested in the Cardiff City Deal over a 20 year period and £115.6m will be invested in the Swansea City Deal over a 15 year period. The government remains committed to agreeing a North Wales Growth Deal. Further detail on the funding of the Cardiff and Swansea City Deals can be found here:<\/p>

<\/p>

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/508268/Cardiff_Capital_Region_City_Deal.pdf<\/a><\/p>

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/611685/Swansea_City_Deal_-_English.pdf<\/a><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4097", "label" : {"_value" : "Biography information for Elizabeth Truss"} } , "answeringMemberConstituency" : {"_value" : "South West Norfolk"} , "answeringMemberPrinted" : {"_value" : "Elizabeth Truss"} , "dateOfAnswer" : {"_value" : "2017-09-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "9346"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-09-14T13:31:35.87Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2017-09-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Local Government: Devolution"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, what the projected spend is for each City Deal in each of the next five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/534", "label" : {"_value" : "Biography information for Chris Ruane"} } , "tablingMemberConstituency" : {"_value" : "Vale of Clwyd"} , "tablingMemberPrinted" : [{"_value" : "Chris Ruane"} ], "uin" : "9345"} , {"_about" : "http://data.parliament.uk/resources/417297", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/417297/answer", "answerText" : {"_value" : "

Lanosterol is still in development and has not yet been trialled on humans.<\/p>

<\/p>

<\/strong><\/p>

<\/p>

The National Institute for Health and Care Excellence is currently developing a clinical guideline on the management of cataracts in adults which is currently expected to be published in June 2017.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-09-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-09-15T12:31:39.5Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-09-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cataracts: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will make available on the NHS lenosterol for the treatment of eye cataracts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "9345"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }